Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: a phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy.
Authors
Blanc, JHubner, Richard A
Li, C
Wang-Gillam, A
Bodoky, G
Dean, A
Shan, Y
Jameson, G
Macarulla Mercade, T
Lee, K
Cunningham, D
Chiu, C
Schwartsmann, G
Braiteh, F
von Hoff, D
Chen, L
Mamlouk, K
de Jong, F
Siveke, J
Affiliation
l'hôpital Haut-Lévêque, Bordeaux, FranceIssue Date
2017-11
Metadata
Show full item recordCitation
Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: a phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy. 2017, 28(suppl_10) Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdx660.035Type
Meetings and ProceedingsISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdx660.035